# Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/burosumab-versus-conventional-therapy-in-children-with-x-linked/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Erik A. Imel,Francis H. Glorieux,Michael P. Whyte,Craig F. Munns,Leanne M. Ward,Ola Nilsson,Jill H. Simmons,Raja Padidela,Noriyuki Namba,Hae Il Cheong,Pisit Pitukcheewanont,Etienne Sochett,Wolfgang Högler,Koji Muroya,Hiroyuki Tanaka,Gary S. Gottesman,Andrew Biggin,Farzana Perwad,Meng Mao,Chao-Yin Chen,Alison Skrinar,Javier San Martín,Anthony A. Portale |
| Citations | 373 |
| DOI | 10.1016/s0140-6736(19)30654-3 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/7179969 |
| OpenAlex ID | https://openalex.org/W2946559089 |
| PMID | 31104833 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Erik A. Imel](https://scholariq.org/researchers/erik-a-imel/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)

## Paper topics

- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Alkaline Phosphatase Research Studies](https://scholariq.org/topics/alkaline-phosphatase-research-studies/)
- [Bone health and treatments](https://scholariq.org/topics/bone-health-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.